LifeMD, Inc. - Common Stock (LFMD)
5.7700
+0.1950 (3.50%)
Lifemd Inc is a biotechnology company focused on advancing personalized medicine by leveraging cutting-edge technology and data analytics to develop innovative diagnostic solutions and therapeutics
Their mission centers around improving patient outcomes through tailored healthcare approaches, harnessing the power of genetic information and biomarkers to better understand individual health traits and disease predispositions. By aiming to provide precise treatment options, Lifemd Inc is dedicated to transforming the landscape of healthcare and empowering patients with actionable insights for managing their health.
Previous Close | 5.575 |
---|---|
Open | 5.850 |
Bid | 5.700 |
Ask | 5.850 |
Day's Range | 5.495 - 6.500 |
52 Week Range | 3.990 - 12.88 |
Volume | 2,771,294 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,976,384 |
News & Press Releases

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · March 11, 2025

After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · March 10, 2025

Via Benzinga · March 11, 2025

U.S. stock futures rose on Tuesday following Monday's heavy selloff. Futures of all four benchmark indices surged in premarket trading.
Via Benzinga · March 11, 2025

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQTSLA) and Palantir Technologies, Inc.
Via Benzinga · March 10, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Via Chartmill · February 21, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · February 21, 2025

Virtual healthcare provider Teladoc Health Inc. (NYSETDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023
Via MarketBeat · July 24, 2024

Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement.
Via InvestorPlace · July 16, 2024

Via Benzinga · June 10, 2024

Him & Hers Health Inc. (NYSEHIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments
Via MarketBeat · June 3, 2024

LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result
Via MarketBeat · May 28, 2024

Via Benzinga · May 9, 2024

Via Benzinga · May 9, 2024

LFMD stock results show that LifeMD beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024

On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.
Via Investor's Business Daily · April 30, 2024

Dexcom earns a lofty No. 5 rank among its peers in the 130-stock Medical-Products industry group. It got a rating upgrade Tuesday.
Via Investor's Business Daily · April 30, 2024

On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.
Via Investor's Business Daily · April 25, 2024

Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.
Via Investor's Business Daily · March 26, 2024

The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.
Via Investor's Business Daily · March 19, 2024

LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024
Via MarketBeat · March 19, 2024

In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday.
Via Investor's Business Daily · March 18, 2024

With growing demand, the market for telemedicine stocks could be worth about $450 billion by the time 2032 rolls around.
Via InvestorPlace · March 14, 2024